Gordon Carl L's Form 4 filing
Theseus Pharmaceuticals, Inc. (THRX) · filed Oct 14, 2021
- Accession no.
- 0000899243-21-040256
- Filed
- Oct 14, 2021
- Trade date
- Oct 12, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market purchases total $10.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gordon Carl LCIK 0001282930 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 12, 2021 | Common Stock | CConversionAcquired | +15,777,018 | –F2 | – | 15,777,018 | Indirect | |
| Oct 12, 2021 | Common Stock | CConversionAcquired | +436,650 | –F2 | – | 436,650 | Indirect | |
| Oct 12, 2021 | Common Stock | PPurchaseAcquired | +562,500 | $16.00 | +$9,000,000 | 16,339,518 | Indirect | |
| Oct 12, 2021 | Common Stock | PPurchaseAcquired | +62,500 | $16.00 | +$1,000,000 | 499,150 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 12, 2021 | Common Stock | CConversionDisposed | −14,903,718 | –F2 | – | 0 | Indirect | |
| Oct 12, 2021 | Common Stock | CConversionDisposed | −873,300 | –F2 | – | 0 | Indirect | |
| Oct 12, 2021 | Common Stock | CConversionDisposed | −436,650 | –F2 | – | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The reported security converted into the issuer's Common Stock on a one-for-one basis automatically immediately prior to the closing of the issuer's initial public offering without payment of further consideration. The shares have no expiration date.
Referenced by the price of 2 transactions in Table I and 3 transactions in Table II.